4,412 results found

In UCB, Inc. v. Accord Healthcare, Inc., Nos. 16-2610, 16-2683, 16-2685, 16-2698, 16-2710, 17-1001 (Fed. Cir. May 23, 2018), the CAFC affirmed the district court's holding that the asserted claims...

In Gilead Sciences, Inc. v. Merck & Co. Inc., Nos. 16-2302, 16-2615 (Fed. Cir. Apr. 25, 2018), the CAFC affirmed the district court's finding that misconduct attributable to Merck barred it ...

In Mylan Pharmaceuticals Inc. v. Research Corporation Technologies, Inc., the CAFC held that appellants, who had joined the IPR proceeding below under 35 U.S.C. § 315, had standing to appeal but affirmed that ...

In University of California v. Broad Institute, Inc., No. 2017-1907 (Fed. Cir. Sept. 10, 2018), the CAFC affirmed the PTAB's holding that there was no interference-in-fact between a pending University

In Sirona Dental Systems GmbH v. Institut Straumann AG, Nos. 17-1341, 17-1403 (Fed. Cir. June 19, 2018), the CAFC affirmed-in-part, vacated-in-part, and remanded-in-part the ...

In Natural Alternatives International, Inc. v. Iancu., No. 2017-1962 (Fed. Cir. Oct. 1, 2018), the CAFC affirmed the PTAB's priority determination invalidating Natural Alternative's patent directed to a human dietary supplement that increases the anaerobic working capacity of muscle and other tissues.

In Barry v. Medtronic, Inc., No. 17-2463 (Fed. Cir. Jan. 24, 2019), the CAFC majority affirmed the district court's findings that Dr. Barry's system and method claims were not invalid

In Mayo Foundation for Medical Education and Research v. Iancu, No. 2018-2031 (Fed. Cir. Sept. 16, 2019), the Federal Circuit affirmed the district court's decision that Patent Term Adjustment is ...

In Momenta Pharmaceuticals, Inc. v. Bristol-Meyers Squibb Co., No. 17-1694 (Fed. Cir. Feb. 7, 2019), the CAFC dismissed Momenta's appeal from a final written decision of the PTAB for lack of standing.

The Federal Circuit denied Ciena Corporation's motion to vacate the PTAB's final written decision and remand for further proceedings consistent with Arthrex, Inc. v. Smith & Nephew, Inc.

Medtronic appealed PTAB decisions in two IPR proceedings upholding all challenged claims directed to pedicle screws for spinal derotation surgery.

In Medtronic, Inc. v. Barry, Nos. 17-1169, 17-1170 (Fed. Cir. June 11, 2018), the CAFC vacated the PTAB's conclusion that a video and presentation describing techniques for spinal derotation surgery...

In OSI Pharmaceuticals, LLC v. Apotex Inc., No. 2018-1925 (Fed. Cir. Oct. 4, 2019), the CAFC reversed the PTAB's conclusion that a reasonable factfinder could conclude a person of ordinary skill...

In Facebook, Inc. v. Windy City Innovations, LLC, the Federal Circuit denied Appellant's petition for rehearing en banc but granted their petition for panel rehearing in order to withdraw and replace the original March 18, 2020 opinion.

In Schwendimann v. Neenah, Inc., No. 22-1333 (Fed. Cir. Oct. 6, 2023), the Federal Circuit affirmed the Patent Trial and Appeal Board's ("Board") holding that all claims of U.S. Patent Nos. RE41,623, 7,754,042, and 7,766,475 and claims 1–6, 8–21, and 24–31 of U.S. Patent No. 7,749,581.

In Guangdong Alison Hi-Tech Co. v. International Trade Commission, No. 2018-2042 (Fed. Cir. Aug. 27, 2019), the Federal Circuit affirmed the ITC's findings that the claims of U.S.

The Court rejected the purported novelty of using a downloadable application, reasoning that the application in substance was described functionally...

In ZyXEL Communications Corp. v. UNM Rainforest Innovations, No. 22-2220 (Fed. Cir. July 22, 2024), the Federal Circuit affirmed-in-part, reversed-in-part, and remanded...